Global MetabolicTesting Market, by Product Type (Metabolic Carts (Portable and Bench-top),Body Composition Analyzers (Portable and Bench-top), and ECGs/EKGs (Portableand Bench-top)), by Test Type (VO2 Max Analysis, RMR Analysis, and BodyComposition Analysis), by End User (Hospitals & Clinics, Sports PerformanceLab, and Home Care Settings), and by Region (North America, Latin America,Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 451.5 Mn in2018, and is projected to exhibit a CAGR of 7.6% during the forecast period(2018–2026).
Increasing launch of advancedmetabolic testing devices and high prevalence of lifestyle diseases is expectedto support the global metabolic testing market growth. Major players in themarket are also focused on investing in research and development of novelmetabolic testing devices. For instance, in 2017, InBody Co., Ltd. introducedInBody band 2, which is a fusion of body composition analyzers and fitnesstrackers. In March 2018, Cosmed srl launched Q-NRG — a metabolic monitor formeasuring energy expenditure in spontaneous breathing and mechanically ventilatedpatients admitted in ICU.
Browse 35 Market Data Tables and34 Figures spread through 179 Pages and in-depth TOC on Global MetabolicTesting Market by Product Type (Metabolic Carts (Portable and Bench-top), BodyComposition Analyzers (Portable and Bench-top), and ECGs/EKGs (Portable and Bench-top)),by Test Type (VO2 Max Analysis, RMR Analysis, and Body Composition Analysis),by End User (Hospitals & Clinics, Sports Performance Lab, and Home CareSettings), and by Region (North America, Latin America, Europe, Asia Pacific,the Middle East, and Africa) - Global Forecast to 2026
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1652
High prevalence of lifestylediseases is expected to propel demand for metabolic testing systems which inturn is expected to support global metabolic testing market growth over theforecast period. For instance, according to a report published by StrokeAlliance for Europe (SAFE) in 2017, incidence of stroke is expected to increaseby 34% in Europe during 2015-2035. Moreover, according to the same source,number of people living with stroke is expected to increase by around 25%between 2015 and 2035 from 3,718,785 million in 2015 to 4,631,050 by 2035. Keyplayers in the market are focused on adopting merger and acquisition strategiesin order to expand their product portfolio and enhance their market share. Forinstance, In May 2018, GE Healthcare announced a marketing collaboration agreementwith FitTrace, a company that offers cloud-based software for analysis andreporting of body composition. Restraints Lifestyle diseases are still notconsidered as extremely serious and fatal in developed as well as emergingeconomies. Low awareness among people regarding metabolic testing and need forscreening, prevention, and monitoring of lifestyle diseases is also expected torestrain the market growth.
Two test are majorlyconducted/used in metabolic testing. Resting Metabolic Rate (RMR) analysis isrequired in ICUs for hospitalized patients to track their health status and todevise precise nutritional requirements for such patients on the basis of theirRMR analysis. VO2 max analysis is required by sports professionals andathletes. (so, these two tests have limited target population which mayrestrain growth of the market). Body composition analysis is not performedextensively other than by fitness enthusiasts (to have high muscle to fat ratiofor a muscular physique) and other purposes. These factors are expected torestrain growth of the market up to certain extent.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/metabolic-testing-market-1652
Key Takeaways of the MetabolicTesting Market:
The global metabolic testingmarket is expected to exhibit a CAGR of 7.6% during the forecast period (2018 –2026), owing to increasing product launches and approvals and robust pipelineof novel metabolic testing devices
North America metabolic testingmarket is expected to hold dominant position in the global metabolic testingmarket over the forecast period. This is due to presence of large customer baseand key players in the region that are increasingly focused on new productlaunches. For instance, in January 2019, KORR Medical Technologies launchedMetabolic Meal Plan application, which can help clinicians to implement, manage,and track clients’ weight-loss regimens.
Europe metabolic testing marketis expected to account for the second largest market share in the globalmetabolic testing market due to presence of key manufacturers and their activefocus on research and development of new products. For instance, in November2017, Vizient, Inc., a major healthcare performance improvement company,bestowed '2017 Innovative Technology designation' to COSMED srl’s K5 wearablemetabolic system.
Major players operating in themetabolic testing market include, COSMED srl, Vyaire Medical, Inc., GerathermMedical AG, MGC Diagnostics Corporation, CORTEX Biophysik GmbH, GeneralElectric Company, Microlife Medical Home Solutions, Inc., OSI Systems, Inc.,AEI Technologies, Inc., and KORR Medical Technologies, Inc.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1652
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
Coherent MarketInsights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
